Colonial Trust Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.4K Hold
352
– – ﹤0.01% 633
2026
Q2
$5.64K Hold
352
– – ﹤0.01% 653
2026
Q1
$6.52K Hold
352
– – ﹤0.01% 581
2025
Q4
$5.49K Hold
352
– – ﹤0.01% 572
2025
Q3
$5.15K Hold
352
– – ﹤0.01% 570
2025
Q2
$5.44K Hold
352
– – ﹤0.01% 582
2025
Q1
$5.23K Hold
352
– – ﹤0.01% 567
2024
Q4
$4.66K Hold
352
– – ﹤0.01% 571
2024
Q3
$5K Hold
352
– – ﹤0.01% 622
2024
Q2
$4.56K Hold
352
– – ﹤0.01% 618
2024
Q1
$4.89K Hold
352
– – ﹤0.01% 698
2023
Q4
$5.02K Sell
352
-1
-0.3% -$14 ﹤0.01% 606
2023
Q3
$5.46K Hold
353
– – ﹤0.01% 597
2023
Q2
$5.55K Hold
353
– – ﹤0.01% 611
2023
Q1
$5.82K Hold
353
– – ﹤0.01% 595
2022
Q4
$5.51K Buy
+353
New +$4.93K ﹤0.01% 599

Other funds holding TAK

Colonial Trust Advisors's TAK Position: Q3 2026 in Review

Colonial Trust Advisors held its Takeda Pharmaceutical (TAK) position steady in Q3 2026 at 352 shares worth $6.4K. The position accounts for ﹤0.01% of the portfolio, ranked #633.

Colonial Trust Advisors first reported a position in TAK in Q4 2022 and has held it in 16 quarters since. The position peaked at $6.52K in Q1 2026. 400 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Colonial Trust Advisors held 352 shares of Takeda Pharmaceutical worth $6.4K as of Q3 2026.
  • Colonial Trust Advisors left its Takeda Pharmaceutical share count unchanged in Q3 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q3 2026, its #633 holding.
  • Colonial Trust Advisors first reported a position in Takeda Pharmaceutical in Q4 2022 and has held it in 16 quarters since.
  • Colonial Trust Advisors's Takeda Pharmaceutical position peaked at $6.52K in Q1 2026.
  • 400 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Colonial Trust Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.